A B S T R A C T The purpose of the present study was to evaluate the significance of immunogenetic factors on the survival of pancreatic allografts in beagle dogs. Donors and recipients were leukocyte antigen (DLA)-typed and mixed lymphocyte culture (MLC)-tested. Recipients were made diabetic by total pancreatectomy and immediately implanted intraperitoneally with a vascularized, free-draining (duct unligated) pancreatic segmental (FDPS) allograft. Two groups of dogs were studied. In group I consisting of donor-recipient littermates, recipients were immunosuppressed with prednisone and azathioprine (n = 16 dogs), or not immunosuppressed (n = 4). In group II, recipients were made specifically unresponsive by total body radiation, autologous marrow implantation, and kidney transplantation from DLA-MLC identical donors, 1 yr before FDPS transplantation from the corresponding original kidney donors.
INTRODUCTION
Transplantationi of the endocrine pancreas has been under intensive study during the past several years (1) (2) (3) (4) (5) (6) . Although numerous approaches have been used, we have found that heterotopic intraperitoneal implantation of the immediately vascularized, free-draining distal pancreatic segment (FDPS)l is technically feasible (7) (8) (9) , eliminating certain complications associated with attempts to anastomose the pancreatic duct (10, 11) . However, because of strong immunogenetic disparities in randomly-bred or pure-bred strains of pigs (7, 8) and randomly-bred dogs (9) , FDPS allografts rarely survived longer than 45 d, and, therefore, longterm observations were lacking.
The present experiments were performed in beagle dogs with defined histocompatibilities to permit longterm study of (a) the immunogenetic factors affecting pancreatic allograft survival, and (b) the evolution of immunologic, functional, and morphological changes in recipients of FDPS allograft that either undergo rejection or are indefinitely accepted.
METHODS
Animilals. Two groups of beagles were studied. Group I consisted of 20 adult donor-recipient littermate pairs weighing between 10 and 15 kg. The animals were purchased from Marshall Laboratories in North Rose, N. Y. The five beagles in group II were older males and females of the Cooperstown colony, which had been inbred for many years (12) . In group II, pairs of donors and recipients had been previously selected and used for kidney transplantation on the basis of extensive dog leukocyte antigen (DLA) haplotyping and pedigree-determined identity as previously described (13) . A state of specific allogeneic unresponsiveness had been produced in the recipients by supralethal x irradiation, followed by reconstitution with stored autologous bone marrow and carefully timed kidney transplantation from a matched donor. Kidney allografts had survived in these recipients for more than 2 yr in the absence of immunosuppression. In the current study in group II, the original kidney donors also served as donors of FDPS allografts, and each pancreatic allograft was transplanted into the same dog that had been the recipient of a kidney from that donor. In conducting the research in this report, the investigators adhered to the Guide for Laboratory Animal Facilities and Care of the Institute of Laboratory Animal Resources, National Academy of Sciences-National Research Council.
Operative techniques. The methods of preparation of the FDPS graft and implantation in the recipient have been previously described (7) (8) (9) . Briefly, in one operative procedure, the recipient animals were made diabetic by total pancreatectomy, immediately followed by intraperitoneal transplantation ofthe left pancreatic limb of the donor (about one-third of the pancreas). The vascular anastomoses were performed using the splenic artery and vein of the graft and the iliac artery and vein of the recipient. The pancreatic duct of the graft was left unligated to drain freely into the peritoneal cavity. Postoperatively, the Immunosuppressive management. Immunosuppression consisted of intraoperative intravenous administration of 5 mg/ kg of azathioprine and 2 mg/kg of methylprednisolone. The post-operative regimen consisted of prednisone 2 mg/kg on day 1, then decreasing doses every 3 d, to a daily maintenance dose of 0.4 mg/kg by day 30. Azathioprine was given in a dose of 5 mg/kg for 3 d, 4 mg/kg for 3 d, 3 mg/kg for 3 d, and then as a 2.5 mg/kg daily maintenance dose subsequently.
Histocompatibility studies and immunological monitoring. Serotyping of erythrocyte antigens and peripheral blood lymphocyte (PBL) antigens (DLA) was performed on all animals. Animals in group I were also DLA genotyped by testing the sires and/or dames of each litter (Dr. Robert Bull, Mfichigan State University, East Lansing, mich.).
Primary mixed lymphocyte culture (MLC) assays were performed as previously described in our laboratory (14) . Briefly, microcultures were prepared in micro-titer plates containing 1 x 105 PBL of the recipient dog as responding cells and 1
x 105 x irradiated PBL ofthe donor (or autologous x irradiated PBL) as stimulator cells in 0.2 ml of RPMI 1640 medium supplemented with 15% heat-inactivated "normal" dog serum, 1% L-glutamine, 1% penicillin-streptomycin, and 1% preservative-free heparin (complete medium). The cultures were incubated in a humidified atmosphere of7% CO2 for 3, 5,7, and 9 d, then pulse-labeled with 1 ,uCi of [3H]thymidine for 18 h before processing in the Mash II microharvester (15) for liquid scintillation counting (Packard Instrument Co., Inc., Downers Grove, Ill.).
For cell-miiediated lymphocytotoxicity (CNIL) assays, cytotoxic effector cells were generated by culturing recipient PBL as responding cells with donor x irradiated PBL as stimulator cells in 8-d macro-MLC (16) . Recipient PBL were also cultured in the presence of autologous x irradiated cells as controls. Donor PBL used as target cells were labeled with radioactive sodium chromate (51Cr) (Amersham Corp., Arlington Heights, Ill.) by incubating 5 x 106 cells in 0.2 ml of RPMI 1640, containing 10% fetal calf serum with 50 ,uCi of51Cr at 37°C for 1 h. The cells were washed four times with medium at 40C and suspended at a concentration of 106 cells/ml. The CML assays were performed in 4-ml tubes (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) containing 2 x 106 recipient effector cells (or autologous controls) and 0.25 x 106 5'Cr-labeled donor cells as targets in a total volume of 1.05 ml. After 18 h of incubation in a humidified 7% CO2 atmosphere at 37°C, 1 ml of cold medium was added and the tubes were centrifuged. The decanted supernatants and pellets were then counted in a gamma counter (Packard Instrument Co., Inc.). The specific 51Cr release from donor cells was calculated by the equation of Brunner (17) .
Antibody-dependent cell-mediated cytotoxicity assays were performed employing 5lCr-labeled donor lymphocytes as targets. The test was performed in a 4-ml tube (Falcon Labware) with 2 x 106 effector cells of either the recipient or a normal control and 0.25 x 106 51Cr-labeled donor target cells sensitized with an appropriate dilution of recipient serum (putative antibody). Target cells treated with fetal calf serum served as negative controls, and cells treated with rabbit anti-dog lymphocyte serum, or repeatedly frozen and thawed, served as positive controls. After 6 h, the incubation was terminated, the tubes centrifuged, and the radioactivity in the supematants determined in a gamma counter. The specific 51Cr release was determined (Brunner equation) with normal release values calculated from fetal calf serum-treated cells (18) .
Pancreatic islet function tests. Postoperatively, serum glucose concentrations were determined (Beckman glucose analyzer, Beckman Instruments, Inc., Fullerton, Calif.) daily at 0900 after an overmight fast. Intravenous glucose tolerance tests (IVGTT) were performed weekly, after an overnight fast, and serum glucose and immunoreactive insulin (19) concentrations were measured just before (0 min) and at 5, 10, 15, 20, 30 , and 60 min after intravenous injection of glucose, 0.5 g/kg body wt. Serum cholesterol, triglycerides, liver enzymes, and complete blood counts were also performed twice weekly.
Morphologic studies. Biopsies ofthe FDPS allografts were taken, at laparotomy, 6 mo after transplantation in long-term survivors. The tissue was fixed in buffered formalin and stained with hematoxylin and eosin, and also fixed in Bouin's solution and stained with aldehyde fuchsin. A small aliquot of tissue was weighed and assayed for insulin content after ex-traction in acid-ethanol (20 sponsive recipients of kidneys from donors that had been previously extensively genotyped and found to be DLA identical and MLC nonreactive before kidney transplantation (13) were tested in MLC against their specific donors again at the beginning of the present study. This group did not need immunosuppression due to the specific unresponsive state previously conferred upon them by x irradiation and autologous bone marrow transplantationi (13) , and therefore, provided a control for the effects of long-term immunosuppression (group I) oIn FDPS graft function. Also, study of this group tested the feasibility of transplanting kidneyr and pancreas in the same recipienit. Skin grafts from the kidney donors had been known to be occasionially rejected, despite unaltered renal function in the recipients (13) . Table II shows that MLC reactivity was definitely present in twvo of these four specifically unresponsive recipients at the onset of the present study, nevertheless graft survival was indefinite (>10 Imlo).
Morphologic chantges in the parncreatic allografts. Once functional rejection of the FDPS allografts was detected, irreversible morphologic changes had already occurred. Thus, grafts biopsied within 24 h after hyperglycemia ensued, were, with one exception, completely necrotic. This finding was present in eight of eight MLC reactive pairs in which early rejection occurred (< 14 d, (Fig. 2b) . This striking finding was not observed in previous short-term studies (7) (8) (9) in which the exocrinie portion of nonrejecting grafts wvas still intact, and virtually unchanged from the appearance at the time of transplantation (Fig. 2a) . Although similar predominance of islet tissue and absence ofexocrine components was observed in the nonimmunosuppressed specifically unresponsive recipients (Fig. 2c) , there was a more marked degree of fibrosis in these grafts ( Fig. 3c and d ) than in the immunosuppressed recipients ( Fig. 3a and b ).
In the twro NMLC noinreactive dogs in which the FDPS allograft survived for >180 d (Table I) (Fig. 4) . Glucose disappearance rates were similar to or only moderately reduced compared to values in the samiie recipients tested before pancreatectomy and transplantation. For this group of three dogs, the pretransplant glucose disappearance rate (mean±+SEM) was 2.68 ±0.45%/min and the post-transplant glucose disappearance rate was 1.81+0.20%/min (P < 0.1, paired t test). Also, serum insulin responses were similar to, or only moderately less than the insulin responses observed in the same recipients tested before pancreatectomy and FDPS transplantation. Although maintenance of normal or near-normal intravenous glucose tolerances and accompanying serum insulin responses could be demonstrated in successful long-term FDPS allograft recipients, it was not possible to detect changes in pancreatic islet function before total graft necrosis occurred in the other dogs in group I. Thus, weekly IVGTT Immunologic motnitorinig. Immunosuppressed animals that were MLC nonreactive before FDPS transplantation exhibited no change in MLC reactivity after transplantation (Fig. 5a) . However, CML responses, which were absent preoperatively, developed shortly before allograft rejectioin in each of the five recipients studied. After rejection, and as the animals became moribund with diabetes, CML reactivity declined. In MLC reactive recipients, 1)oth MLC and CML reactivity decliined markedly in the perirejection period (Fig. 51) ). Table I , before (preoperative) and six mo after (postoperative) FDPS allograft transplantation. Stimulation Index (SI) = R + Dx + R + Rx (Table I) . present methods of islet isolation and transplantation (23, 24) . This may be due to a greater susceptibility to immune damage of isolated islets than of islets situated in the vascularized pancreas. Indeed, we have recently found evidence for tissue specific islet antigens, demonstrable in vitro (25) , and the immunogenicity of these islet antigens may be amplified by currently used enzymatic isolation techniques. Whereas attempts to transplant islets in the human in an allogeneic setting have been routinely unsuccessful (26) (27) (28) (29) , a technique employing intraperitoneal transplantation of a vascularized, FDPS has been used clin- 298 Kyriakides, Rabinovitch, Mintz, Olson, Rapaport, and Miller ically in 13 patients by Sutherland et al. (30, 31) , with term graft survival was possible (7-9). However, a few technical problems and with encouraging results. definitive study to examine the immunogenicity ofalloWe had previously demonstrated, in animal studies, grafts using this technique in experimental animals had that the FDPS technique unexpectedly was not asso-not been performed. Therefore, in the present work, we ciated with autoenzymatic tissue damage and that long-examined various immune mechanisms that might be (Fig. 5a ). This finding differs from observations in humans and mice, in that CML reactivity should not be generated in lymphocytedefined and serologically defined identical pairs, although there are isolated observations to the contrary (33, 34 (Fig. 5b) , in support of observations in our previous studies (35, 36) . In addition, cytotoxic cells also decreased during this period (Fig. 4b ). This could not be attributed to immunosuppressive therapy per se, since in the MLC nonreactors, cytotoxic cells actually appeared in the presence of the same therapy (Fig. 5a) (37) . In any event, immunosuppression, in the dosages used, did not alter the development of these processes and vigorous rejection of the FDPS allograft ensued. An unexpected finding was that the four animals made specifically unresponsive by x irradiation, followed by autologous marrow transplantation, and then kidney transplantation, possessed CML reactivity before FDPS transplants were performed from the original kidney donors (Table II) . Also, two of these animals had low-grade MLC reactivity, and this had not been present during the earlier study in these dogs (13) . Differences in sensitivity of the techniques might account for the disparate MLC findings between the two studies. The other two "adoptively unresponsive" dogs in group II were MLC nonreactive and exhibited CML reactivity. CML reactivity has not previously been observed in untreated MLC nonreactor animals, either in previous studies in our laboratory, or in animals in group I before transplantation in the present study (Fig. 5a ). The findings of CML reactivity (4:4 dogs) and MLC reactivity (2:4 dogs) do not support suppressor cell mechanisms as an explanation for host adaptation to kidney and/or pancreas allografts in the specifically unresponsive animals. Also, since recipient MLC serum blocking factors were not present in this group, enhancement did not appear to be operative as a mechanism of immunoregulation (38) . Although not shown here, all four recipients rejected skin allografts from their respective donors at 6 mo, whereas FDPS and renal function continued for more than 9 mo. The specific unresponsiveness was therefore incomplete. Taken together, the findings suggest that mechanisms other than suppressor cells or enhancement may exist for adaptation of the host to tissue allografts, and that tissue specific antigens may be important in graft rejection (13, 39) .
A discouraging observation in the present study was that allograft rejection and resumption of the diabetic state appeared to be an "all or none" phenomenon ( Fig. 1) Also, assays that miioniitor humiiioral immunity (40, 41) miax-dletect cliaiges l)bfOre irreversil)le rejection of a FDPS allograft has occuirred, and these studclies are in p)rogress.
An encouraging finding was that when FDPS allografts were accepted in immunosuppressed recipients, intravenous glucose tolerances and insulin secretory responses several months after transplantation were similar to those in the corresponding animal before pancreatectomy (Fig. 4) . In agreement with earlier reports of pancreatic transplantation (1, 2) exocrine elements virtually disappeared from the graft, whereas islet tissue survived (Fig. 2b) . In our earlier work, we found that administration of steroids in high doses would inhibit fibrosis and prevent inflammatory degeneration of both segmental pancreatic autografts and allografts durinig the first 30 d (4,42_). This was also found in the immunosuppressed dogs (group I) in the present study (Fig. 3b) . In contrast, despite similar loss of exocrine elements in the non-steroid treated dogs (group II) made unresponsive, fibrosis of the FDPS was not avoided (Fig. 3d) . Similar long-term morphological findings of a sclerosing reaction have been seen in animals and patients in which neoprene was injected into the pancreatic duct to completely ablate the exocrine elements (6, 9, 43) . Although most of these stubjects were treated with steroids, the addition of the sclerosing agent may have been enough to allow the fibrotic process to proceed and confucses interpretation of the histologic appearance, since rejection mechanisms are difficult to dissociate from the inflammatory response set up by neoprene. Thus, paradoxically, the use of diabetogenic steroids, which might be predicted to doom pancreatic allotransplantation in diabetic recipients to failure, has not proven deleterious, at least to date in the present long-term experiments in dogs, or in human recipients of vascularized, free-draining pancreatic segmental allografts (31, 32) .
